216 related articles for article (PubMed ID: 21241837)
1. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
[TBL] [Abstract][Full Text] [Related]
2. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T
Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091
[TBL] [Abstract][Full Text] [Related]
3. DeltaEF1 promotes breast cancer cell proliferation through down-regulating p21 expression.
Hu F; Wang C; Du J; Sun W; Yan J; Mi D; Zhang J; Qiao Y; Zhu T; Yang S
Biochim Biophys Acta; 2010 Feb; 1802(2):301-12. PubMed ID: 20006705
[TBL] [Abstract][Full Text] [Related]
4. deltaEF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineage.
Yang S; Zhao L; Yang J; Chai D; Zhang M; Zhang J; Ji X; Zhu T
J Biomed Sci; 2007 Sep; 14(5):663-79. PubMed ID: 17479358
[TBL] [Abstract][Full Text] [Related]
5. BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Zhang Y; Li M; Zhao L; Chen J; Yang S; Zhang X
Oncol Rep; 2016 Mar; 35(3):1823-30. PubMed ID: 26751737
[TBL] [Abstract][Full Text] [Related]
6. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.
Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T
BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862
[TBL] [Abstract][Full Text] [Related]
7. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
8. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
Fukagawa A; Ishii H; Miyazawa K; Saitoh M
Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
[TBL] [Abstract][Full Text] [Related]
9. δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancer.
Guo S; Li Y; Tong Q; Gu F; Zhu T; Fu L; Yang S
PLoS One; 2012; 7(12):e52380. PubMed ID: 23285017
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
11. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
12. Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.
Yang S; Du J; Wang Z; Yan J; Yuan W; Zhang J; Zhu T
Int J Biochem Cell Biol; 2009 Apr; 41(4):853-61. PubMed ID: 18805502
[TBL] [Abstract][Full Text] [Related]
13. The potential role of regulator of G-protein signaling 16 in cell motility mediated by δEF1 family proteins.
Hoshi Y; Endo K; Shirakihara T; Fukagawa A; Miyazawa K; Saitoh M
FEBS Lett; 2016 Jan; 590(2):270-8. PubMed ID: 26823172
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
15. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
16. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
[TBL] [Abstract][Full Text] [Related]
17. Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.
Tang X; McMullen TPW; Brindley DN
Theranostics; 2019; 9(21):6129-6142. PubMed ID: 31534541
[TBL] [Abstract][Full Text] [Related]
18. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
[TBL] [Abstract][Full Text] [Related]
19. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
[TBL] [Abstract][Full Text] [Related]
20. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
